• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Mary Kay Has Left The Building

anonymous

Guest
Mary Kay, the former CHRO, has left the building. Now that she can no longer threaten everyone with COVID-19 sanctions, she was no longer fulfilled at Patterson Companies. I am sure her new company will be subjected to her thoughts on anything and everything OTHER than generating revenue. Does anyone other than me thing she must have known a wee bit more about the antics of Markie Mark yet turned a blind eye? Might that be why she left all those valuable? stock options on the table?